Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

52.88
-1.5400-2.83%
Volume:554.40K
Turnover:29.49M
Market Cap:5.05B
PE:-12.12
High:54.19
Open:53.79
Low:52.55
Close:54.42
52wk High:63.95
52wk Low:26.74
Shares:95.43M
Float Shares:89.89M
Volume Ratio:0.52
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3646
EPS(LYR):-4.3646
ROE:-51.76%
ROA:-32.58%
PB:8.67
PE(LYR):-12.12

Loading ...

Aug 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 03, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 10, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 14, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jan 14, 2021

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Aug 17, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]